Comparison of Pulmicort® pMDI plus Nebuhaler® and Pulmicort® Turbuhaler® in asthmatic patients with dysphonia

Respiratory Medicine

Volumn 94, Issue 5, 2000, Pages 448-453

  Crompton, G K ^a   Sanderson, R ^b   Dewar, M H ^a   Matusiewicz, S P ^a   Ning, A C W S ^c   Jamieson, A H ^c   McLean, A ^c   Greening, A P ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

^b ST JOHN'S HOSPITAL   (United Kingdom)

^c ASTRAZENECA   (United Kingdom)

Author keywords

Asthma; Dysphonia; Inhaled steroids; Largngoscopy; Nebuhaler ; pMDI; Pulmicort ; Turbuhaler

Indexed keywords

BUDESONIDE; CORTICOSTEROID; BRONCHODILATING AGENT;

ADULT; AGED; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DYSPHONIA; FEMALE; GLOTTIS; HUMAN; INHALER; LARYNGOSCOPY; MAJOR CLINICAL STUDY; MALE; METERED DOSE INHALER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VOCAL CORD; VOICE; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; FORCED EXPIRATORY VOLUME; INHALATIONAL DRUG ADMINISTRATION; LARYNX DISORDER; MIDDLE AGED; NEBULIZER; PHYSIOLOGY; VITAL CAPACITY;

ADMINISTRATION, INHALATION; ADULT; AGED; AGED, 80 AND OVER; ASTHMA; BRONCHODILATOR AGENTS; BUDESONIDE; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LARYNGOSCOPY; MALE; MIDDLE AGED; NEBULIZERS AND VAPORIZERS; VITAL CAPACITY; VOICE DISORDERS; VOICE QUALITY;

EID: 0033625659     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1053/rmed.1999.0762     Document Type: Article

References (11)

1. Settipane G A, Kalliel J N, Klein D E. Rechallenge of patients who developed oral candidiasis or hoarseness with beclomethasone dipropionate. N Engl Reg Allergy Proc. 8:1987;95-97.
2. Toogood J A, Jennings B, Greenway R W, Chung L. Candidiasis and dysphonia complicating beclomethasone treatment of asthma. J Allergy Clin Immunol. 65:1980;145-153.
3. Williamson I J, Matusiewicz S P, Brown P H, Greening A P, Crompton G K. Frequency of voice problems and cough in patients using pressurized aerosol inhaled steroid preparations. Eur Respir J. 8:1995;590-592.
4. Williams A J, Baghat M S, Stableforth D E, Cayton R M, Shenoi P M, Skinner C. Dysphonia caused by inhaled steroids: recognition of a characteristic laryngeal abnormality. Thorax. 38:1983;813-821.
5. Engel T, Heinig J H, Malling H-J, Scharling B, Nikander K, Madsen F. Clinical comparison of inhaled budesonide delivered either via pressurized metered dose inhaler or Turbuhaler. Allergy. 44:1989;220-225.
6. ®. Allergy. 49:1994;888-890.
7. Agertoft L, Pedersen S. Importance of the inhalation device on the effect of budesonide. Arch Dis Child. 69:1993;130-133.
8. Thorsson L, Edsbäcker S, Conradsen T-B. Lung deposition from Turbuhaler is twice that from a pressurized metered dose inhaler p-MDI. Eur Respir J. 7:1994;1839-1844.
9. Salzman G A, Pyszczynski D R. Oropharyngeal candidiasis in patients treated with beclomethasone dipropionate delivered by metered-dose inhaler alone and with Aerochamber. J Allergy Clin Immunol. 81:1988;424-428.
10. Toogood J H, Baskerville J, Jennings B, Lefcoe N M, Johansson S A. Use of spacers to facilitate inhaled corticosteroid treatment of asthma. Am Rev Respir Dis. 129:1984;723-729.
11. Toogood J H, Jennings B, Baskerville J, Andersson J, Johansson S A. Dosing regimen of budesonide and occurrence of oropharyngeal complications. Eur J Respir Dis. 65:1984;35-44.